Compartment Syndrome Monitoring Devices Market - By Product (Disposables, Equipment), By Syndrome Type (Acute Compartment Syndrome, Chronic Compartment Syndrome, Abdominal Compartment Syndrome), By End-use & Forecast, 2023 – 2032

Compartment Syndrome Monitoring Devices Market Size

Compartment Syndrome Monitoring Devices Market was valued at around USD 187.6 million in 2022 and is estimated to reach over USD 385.6 million by 2032. This market share is owing to technological advancements, growing incidence of intra-abdominal hypertension, rising prevalence of trauma cases, sports injuries, and chronic diseases among others.
 

The market has been witnessing continuous technological advancements. This includes the development of advanced intra-compartmental pressure (IPC) monitoring devices, such as non-invasive ICP monitoring devices, continuous monitoring systems, and smart wearables. These innovations aimed to improve the diagnosis and management of compartment syndrome.
 

Continuous monitoring systems have been gaining popularity due to their ability to provide real-time data. These devices can help healthcare providers identify increases in pressure early, allowing for timely intervention leading to better treatment outcomes. Moreover, the development of non-invasive methods to monitor compartment pressure allows for better patient compatibility, shorter recovery times, and high safety profile among others. These methods include using ultrasound or near-infrared spectroscopy to estimate pressure without the need for invasive procedures.
 

Furthermore, the use of radio frequency identification (RFID) technology in compartment syndrome monitoring devices is estimated to fuel user preference. Integration of RFID-enabled sensors into compartment pressure monitoring devices helps continuous monitoring of compartment pressure and transmits data wirelessly to a central system allowing healthcare providers to closely monitor pressure changes and respond promptly.
 

Additionally, the commercialization and development of noble products by key market players is set to surge the compartment syndrome monitoring devices market expansion. Compartment syndrome monitoring devices are medical instruments that are designed to measure compartmental pressure that assists in the diagnosis and monitoring of acute, chronic, and abdominal compartment syndrome.

Lack of accurate diagnosis of compartment syndrome is among the major factors hampering the adoption of compartment syndrome monitoring device procedures. These devices require regular calibration and maintenance to ensure accurate readings that require complex or specialized training or expertise. Moreover, symptoms of compartment syndrome can vary from person to person and may mimic other conditions, such as muscle strains or fractures. This variability can make it challenging to recognize the condition.
 

Furthermore, patients with compartment syndrome often have other injuries, such as fractures or soft tissue injuries, which can divert attention from the underlying compartment syndrome. In addition, some compartment syndrome monitoring devices may come with advanced features, such as real-time data analysis, alarms, and connectivity options. While these features can be valuable, they may also add complexity to device operation.

COVID-19 Impact

The COVID-19 pandemic emerged as a drastic public health concern and the outbreak has affected the global economy, impacting & proliferating the disease burden. Multiple sectors have witnessed notable transitions including the healthcare industry. Hospital admissions and therapeutics associated with the COVID-19 pandemic were prioritized affected other medical services and elective medical procedures were postponed. Thus, such developments slowed down the compartment syndrome monitoring devices market growth in a positive manner during 2020. Furthermore, SARS-CoV-2 predominantly impacts & disrupts the respiratory system, although the virus has several non-respiratory symptoms related to its onset.
 

Multiple clinical studies performed by the National Centers for Biotechnology Information and Wound Care Learning Network documented certain cases related to compartment syndrome among patients suffering from COVID-19. As per the NCBI, in 2021, a wide range of unorthodox manifestations of coronavirus, including acute kidney injury (AKI) impacted around 25% of severely affected COVID-19 patients. Also, this development is associated with higher mortality and morbidity among SARS-CoV-2-infected patients. The application of mechanical ventilation for COVID-19 patients suffering from AKI is associated with the surged risk of intra-abdominal hypertension (IAH) in patients seeking treatment in the ICU.
 

Moreover, the patients affected with COVID-19 majorly exhibit two correlated pathologies namely COVID–19–related thromboembolic & hemorrhagic coagulopathies and capillary leak syndrome. These phenomena possess the potential to develop intense swelling of third spaces that contain muscle & neurovascular bundles. These conditions lead to the development of compartment syndrome, thereby increasing the risk factor among COVID-19 patients.
 

Compartment Syndrome Monitoring Devices Market Trends

The growing demand for compartment syndrome monitoring devices has had a significant impact on the market growth across the globe. The increase in trauma cases, sports injuries, and other chronic diseases across the globe has led to a rise in acute compartment syndrome (ACS), thereby propelling the demand for compartment syndrome monitoring devices for diagnosis and management. Several studies showed that fractures are the most common cause of ACS, accounting for about 75% of the cases. After fractures, the most common cause of ACS is soft tissue injuries resulting from trauma causes and sports injuries.
 

According to the National Safety Council (NSC), in 2022, exercise equipment accounted for an estimated 445,642 injuries, the most in any sports and recreation category. The increasing number of people participating in sports and exercise such as high-intensity interval training will promote the disease burden. The use of compartment syndrome monitoring devices by affected patients is set to surge the market progress. Additionally, compartment syndrome monitoring devices can be used preventively in sports where repetitive motions or over-exertion can increase the risk of compartment syndrome. These devices can track pressure changes during training sessions to identify patterns and make adjustments to avoid overuse injuries.
 

Compartment Syndrome Monitoring Devices Market Analysis

The equipment segment accounted for the majority compartment syndrome monitoring devices market share in 2022 and is anticipated to flourish the industry growth to reach USD 285.7 million by 2032. This dominant market share is attributable to the novel developments in compartment syndrome monitoring equipment that are anticipated to promote their acceptance rate. For instance, Millar, Inc. developed the Mikro-Cath, a novel pressure monitoring modality that is increasingly employed in monitoring compartment syndrome. This product provides high-fidelity pressure assessments to deliver reliable and accurate pressure signals that assist trauma surgeons in providing support and facilitating compartment syndrome diagnosis. Such product advancements, delivering higher precision along with ease-in-use are expected to fuel the market progress positively.
 

Based on syndrome type, the abdominal compartment syndrome type accounted for USD 64 million in 2022 and is estimated to grow at 7.5% CAGR during the analysis timeframe. The substantial compartment syndrome monitoring devices market growth is majorly attributed to the increasing prevalence of abdominal compartment syndrome and IAH. Abdominal compartment syndrome is usually reported after a rise in the abdominal cavity pressure beyond 20 mm Hg. This rise may result in multiorgan dysfunction that propels the risk of surged mortality & morbidity rates. As per the Annals of Intensive Care, in 2020, the abdominal compartment syndrome prevalence was around 3.6%, and the IAH prevalence accounted for around 33% in a similar cohort.
 

The hospital segment held a significant compartment syndrome monitoring devices market share in 2022 and is predicted to experience considerable growth to reach USD 179.3 million by 2032. This considerable market growth is primarily attributed to the availability of accurate compartment pressure measurement equipment and the rise in the prevalence of intra-abdominal hypertension (IAH). IAH directly impacts abdominal organs including the liver and kidney; it also has the potential to lead to organ dysfunction. The condition is increasingly prevalent among patients receiving mechanical ventilation. Also, hospitals provide an efficient and practical approach for measuring intra-abdominal pressure measurement and validation.
 

The North America compartment syndrome monitoring devices market accounted for the highest revenue share of over 55% in 2022 and is projected to flourish the business growth to reach USD 215.3 million by 2032. The rising prevalence of compartment syndrome along with other chronic diseases that act as a precursor to the condition is anticipated to expedite the market demand. Moreover, the presence of prominent players such as Millar, Inc., MY01, Inc., and Critical Care Diagnostics (C2Dx), Inc. among others is engaged in the new product development & commercialization that facilitates the industrial expansion in the region.
 

Compartment Syndrome Monitoring Devices Market Share

Some of the major market players operating in the compartment syndrome monitoring devices market are:                                   

• Millar, Inc.
• Medline Industries, Inc.
• Becton
• Dickenson and Company
• MY01, Inc.
• Critical Care Diagnostics (C2Dx), Inc.
• Potrero Medical
• ConvaTec Group
• Biometrix Ltd. (3i Group plc)
• Spiegelberg GmbH & Co. KG.

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.
 

Compartment Syndrome Monitoring Devices Industry News:

• In August 2021, Millar, Inc., and Schwarzer Cardiotek announced a strategic collaboration to integrate the Millar Mikro-Cath and the EP-Tracer recording system. This integration enabled the firm to improve clinician workflows. This development helped the company to leverage technical expertise, further gaining a competitive edge.
   
• In May 2021, MY01, Inc. received U.S. Food and Drug Administration 510(k) clearance for its MY01 Continuous Compartment Pressure Monitor with full Bluetooth capabilities. This product incorporates a proprietary and innovative modality to provide a reliable, precise continuous pressure microsensor directly within the muscle. This approval will help the company in driving product sales and revenue generation.
   

Compartment syndrome monitoring devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million)

• Disposables
• Equipment

By Syndrome type, 2018 - 2032 (USD Million)

• Acute compartment syndrome
• Chronic compartment syndrome
• Abdominal compartment syndrome

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE